0001246360-12-002906.txt : 20120629 0001246360-12-002906.hdr.sgml : 20120629 20120629192011 ACCESSION NUMBER: 0001246360-12-002906 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120627 FILED AS OF DATE: 20120629 DATE AS OF CHANGE: 20120629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quinn Anthony CENTRAL INDEX KEY: 0001532219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 12937149 MAIL ADDRESS: STREET 1: 128 SPRING STREET, SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 4 1 form.xml PRIMARY DOCUMENT X0305 4 2012-06-27 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532219 Quinn Anthony 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421 false true false false SVP, Chief Medical Officer Stock Option (Right to Buy) 40.74 2012-06-27 4 A false 45000 0 A 2022-06-27 Common Stock 45000 45000 D 25% of the total number of shares subject to the option vest and become exercisable on June 27, 2013 and 1/36 of the remainder of the shares subject to the option shall vest and become exercisable monthly thereafter. /s/ Marc A. Rubenstein, Attorney-in-Fact 2012-06-29